Below are the financial statements of Core Scientific, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in thousands of USD | 2024 as of 2024-12-31 | 2023 as of 2023-12-31 |
|---|---|---|
| Assets | — | — |
| Current assets | — | — |
| Cash and cash equivalents | 836,197a | 50,409a |
| Restricted cash | 783a | 19,300a |
| Accounts receivable | 1,025a | 1,001a |
| Digital assets | 23,893a | 2,284a |
| Prepaid expenses and other current assets | 42,064a | 24,022a |
| Total current assets | 903,962a | 97,016a |
| Property, plant and equipment, net | 556,342a | 585,431a |
| Operating lease right-of-use assets | 114,472a | 7,844a |
| Other noncurrent assets | 24,039a | 21,865a |
| Total assets | 1,598,815a | 712,156a |
| Liabilities and stockholders’ deficit | — | — |
| Current liabilities | — | — |
| Accounts payable | 19,265a | 154,751a |
| Accrued expenses and other current liabilities | 69,230a | 179,636a |
| Deferred revenue | 18,134a | 9,830a |
| Operating lease liabilities, current portion | 9,974a | 77a |
| Finance lease liabilities, current portion | 1,669a | 19,771a |
| Notes payable, current portion | 16,290a | 124,358a |
| Total current liabilities | 134,562a | 488,423a |
| Operating lease liabilities, net of current portion | 97,843a | 1,512a |
| Finance lease liabilities, net of current portion | 3a | 35,745a |
| Convertible and other notes payable, net of current portion | 1,073,990a | 684,082a |
| Contingent value rights | 4,272a | 0a |
| Warrant liabilities | 1,097,285a | 0a |
| Other noncurrent liabilities | 11,040a | 0a |
| Total liabilities not subject to compromise | 2,418,995a | 1,209,762a |
| Liabilities subject to compromise | 0a | 99,335a |
| Total liabilities | 2,418,995a | 1,309,097a |
| Stockholders’ deficit | — | — |
| Preferred stock | 0a | 0a |
| Common stock | 3a | 36a |
| Additional paid-in capital | 2,915,035a | 1,823,260a |
| Accumulated deficit | -3,735,218a | -2,420,237a |
| Total stockholders’ deficit | -820,180a | -596,941a |
| Total liabilities and stockholders’ deficit | 1,598,815a | 712,156a |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Core Scientific’s data sources below and access millions more through our Disclosure Search.